ProQR Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.

About PRQR

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. 

CEO
Daniel Anton de Boer
CEODaniel Anton de Boer
Employees
187
Employees187
Headquarters
Leiden, Zuid-Holland
HeadquartersLeiden, Zuid-Holland
Founded
2012
Founded2012
Employees
187
Employees187

PRQR Key Statistics

Market cap
291.86M
Market cap291.86M
Price-Earnings ratio
-3.92
Price-Earnings ratio-3.92
Dividend yield
Dividend yield
Average volume
738.42K
Average volume738.42K
High today
$1.99
High today$1.99
Low today
$1.86
Low today$1.86
Open price
$1.88
Open price$1.88
Volume
1.31M
Volume1.31M
52 Week high
$3.10
52 Week high$3.10
52 Week low
$1.33
52 Week low$1.33

Stock Snapshot

With a market cap of 291.86M, ProQR Therapeutics(PRQR) trades at $1.99. The stock has a price-to-earnings ratio of -3.92.

On 2026-08-05, ProQR Therapeutics(PRQR) stock moved within a range of $1.86 to $1.99. With shares now at $1.99, the stock is trading +7.3% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 1.31M, compared to an average daily volume of 738.42K.

The stock's 52-week range extends from a low of $1.33 to a high of $3.10.

The stock's 52-week range extends from a low of $1.33 to a high of $3.10.

PRQR News

TipRanks 2d
Major Insider Move: ProQR’s CEO Makes Bold Bet on the Company’s Future

New insider activity at ProQR ( (PRQR) ) has taken place on August 3, 2026. Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make...

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own PRQR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.